Search
for
Sort by
Research 91–120 of 341
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Dermatological adverse events with taxane chemotherapy
- Recognition and management of <i>Staphylococcus aureus</i> toxin‐mediated disease
- Cutaneous manifestations of systemic lupus erythematosus
- Drug-Induced Skin, Nail and Hair Disorders
- Cutaneous reactions to recombinant cytokine therapy
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- THE DISEASE SPECTRUM, EPIDEMIOLOGY, AND ETIOLOGY OF TOXIC-SHOCK SYNDROME
- Adverse Cutaneous Reactions to Antipsychotics
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Graft-versus-host disease
- Cutaneous manifestations of HIV infection other than Kaposi's sarcoma: Clinical and histologic aspects
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Oral Retinoids in Dermatology
- Adverse Cutaneous Reactions to Antidepressants
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- SLE and Serum Complement: Causative, Concomitant or Coincidental?
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- Toxic shock syndrome: Recent developments in pathogenesis
- Syphilis: A great imitator
- Patients with specific skin disorders who are affected by COVID ‐19: What do experiences say about management strategies? A systematic review
- Syphilitic Alopecia: Case Reports and Trichoscopic Findings
- Parkinson's disease and skin
- Hypersensitivity Reactions to Anticoagulant Drugs
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Adverse Drug Reactions in HIV/AIDS Patients on Highly Active Antiretro Viral Therapy: A Review of Prevalence
- Skin signs of systemic diseases